202 related articles for article (PubMed ID: 34959687)
1. Thymoquinone Inhibits Growth of Acute Myeloid Leukemia Cells through Reversal
Al-Rawashde FA; Johan MF; Taib WRW; Ismail I; Johari SATT; Almajali B; Al-Wajeeh AS; Nazari Vishkaei M; Al-Jamal HAN
Pharmaceuticals (Basel); 2021 Dec; 14(12):. PubMed ID: 34959687
[TBL] [Abstract][Full Text] [Related]
2. Thymoquinone Enhances Apoptosis of K562 Chronic Myeloid Leukemia Cells through Hypomethylation of
Al-Rawashde FA; Al-Sanabra OM; Alqaraleh M; Jaradat AQ; Al-Wajeeh AS; Johan MF; Wan Taib WR; Ismail I; Al-Jamal HAN
Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375831
[TBL] [Abstract][Full Text] [Related]
3. Thymoquinone Suppresses Cell Proliferation and Enhances Apoptosis of HL60 Leukemia Cells through Re-Expression of JAK/STAT Negative Regulators.
Almajali B; Al-Jamal HAN; Wan Taib WR; Ismail I; Johan MF; Doolaanea AA; Ibrahim WN; Tajudin SA
Asian Pac J Cancer Prev; 2021 Mar; 22(3):879-885. PubMed ID: 33773553
[TBL] [Abstract][Full Text] [Related]
4. Thymoquinone Induces Downregulation of BCR-ABL/JAK/STAT Pathway and Apoptosis in K562 Leukemia Cells.
Al-Rawashde FA; Wan Taib WR; Ismail I; Johan MF; Al-Wajeeh AS; Al-Jamal HAN
Asian Pac J Cancer Prev; 2021 Dec; 22(12):3959-3965. PubMed ID: 34967577
[TBL] [Abstract][Full Text] [Related]
5. Enhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3-ITD positive acute myeloid leukemia.
Al-Jamal HA; Mat Jusoh SA; Hassan R; Johan MF
BMC Cancer; 2015 Nov; 15():869. PubMed ID: 26547689
[TBL] [Abstract][Full Text] [Related]
6. Thymoquinone Inhibits JAK/STAT and PI3K/Akt/ mTOR Signaling Pathways in MV4-11 and K562 Myeloid Leukemia Cells.
Al-Rawashde FA; Al-Wajeeh AS; Vishkaei MN; Saad HKM; Johan MF; Taib WRW; Ismail I; Al-Jamal HAN
Pharmaceuticals (Basel); 2022 Sep; 15(9):. PubMed ID: 36145344
[TBL] [Abstract][Full Text] [Related]
7. Effect of Decitabine (5-aza-2'-deoxycytidine, 5-aza-CdR) in Comparison with Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) on DNMT1, DNMT3a and DNMT3b, HDAC 1-3, SOCS 1, SOCS 3, JAK2, and STAT3 Gene Expression in Hepatocellular Carcinoma HLE and LCL-PI 11 Cell Lines.
Sanaei M; Kavoosi F; Pourahmadi M
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2089-2098. PubMed ID: 34319031
[TBL] [Abstract][Full Text] [Related]
8. Gene Expression Profiling and Protein Analysis Reveal Suppression of the C-Myc Oncogene and Inhibition JAK/STAT and PI3K/AKT/mTOR Signaling by Thymoquinone in Acute Myeloid Leukemia Cells.
Almajali B; Johan MF; Al-Wajeeh AS; Wan Taib WR; Ismail I; Alhawamdeh M; Al-Tawarah NM; Ibrahim WN; Al-Rawashde FA; Al-Jamal HAN
Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337104
[TBL] [Abstract][Full Text] [Related]
9. Thymoquinone exerts potent growth-suppressive activity on leukemia through DNA hypermethylation reversal in leukemia cells.
Pang J; Shen N; Yan F; Zhao N; Dou L; Wu LC; Seiler CL; Yu L; Yang K; Bachanova V; Weaver E; Tretyakova NY; Liu S
Oncotarget; 2017 May; 8(21):34453-34467. PubMed ID: 28415607
[TBL] [Abstract][Full Text] [Related]
10. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG
World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
12. Silencing of suppressor of cytokine signaling-3 due to methylation results in phosphorylation of STAT3 in imatinib resistant BCR-ABL positive chronic myeloid leukemia cells.
Al-Jamal HA; Jusoh SA; Yong AC; Asan JM; Hassan R; Johan MF
Asian Pac J Cancer Prev; 2014; 15(11):4555-61. PubMed ID: 24969884
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia.
Johan MF; Bowen DT; Frew ME; Goodeve AC; Reilly JT
Br J Haematol; 2005 Apr; 129(1):60-5. PubMed ID: 15801956
[TBL] [Abstract][Full Text] [Related]
14. Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma.
Beldi-Ferchiou A; Skouri N; Ben Ali C; Safra I; Abdelkefi A; Ladeb S; Mrad K; Ben Othman T; Ben Ahmed M
PLoS One; 2017; 12(4):e0174835. PubMed ID: 28369102
[TBL] [Abstract][Full Text] [Related]
15. Thymoquinone-Induced Reactivation of Tumor Suppressor Genes in Cancer Cells Involves Epigenetic Mechanisms.
Qadi SA; Hassan MA; Sheikh RA; Baothman OA; Zamzami MA; Choudhry H; Al-Malki AL; Albukhari A; Alhosin M
Epigenet Insights; 2019; 12():2516865719839011. PubMed ID: 31058255
[TBL] [Abstract][Full Text] [Related]
16. Thymoquinone induces apoptosis in human colon cancer HCT116 cells through inactivation of STAT3 by blocking JAK2- and Src‑mediated phosphorylation of EGF receptor tyrosine kinase.
Kundu J; Choi BY; Jeong CH; Kundu JK; Chun KS
Oncol Rep; 2014 Aug; 32(2):821-8. PubMed ID: 24890449
[TBL] [Abstract][Full Text] [Related]
17. Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells.
Cook AM; Li L; Ho Y; Lin A; Li L; Stein A; Forman S; Perrotti D; Jove R; Bhatia R
Blood; 2014 May; 123(18):2826-37. PubMed ID: 24668492
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
Lee TL; Yeh J; Van Waes C; Chen Z
Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
[TBL] [Abstract][Full Text] [Related]
19. The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer.
Şakalar Ç; İzgi K; İskender B; Sezen S; Aksu H; Çakır M; Kurt B; Turan A; Canatan H
Tumour Biol; 2016 Apr; 37(4):4467-77. PubMed ID: 26500095
[TBL] [Abstract][Full Text] [Related]
20. Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches.
El-Shehawy AA; Elmetwalli A; El-Far AH; Mosallam SAE; Salama AF; Babalghith AO; Mahmoud MA; Mohany H; Gaber M; El-Sewedy T
BMC Complement Med Ther; 2023 Mar; 23(1):69. PubMed ID: 36870998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
